about
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target moleculeCapturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancerComprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanomaUp-regulated Dicer expression in patients with cutaneous melanomaA comparative study of gene-expression data of basal cell carcinoma and melanoma reveals new insights about the two cancers.Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.Use of gene expression and pathway signatures to characterize the complexity of human melanoma.Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanomaRSK1 activation promotes invasion in nodular melanoma.Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanomap63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis.Histology-specific microRNA alterations in melanoma.A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.miRNAs and Melanoma: How Are They Connected?Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.Genome-wide analysis of gene and protein expression of dysplastic naevus cellsMELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression.
P2860
Q27015933-CAA1C45E-2FFE-4169-BC09-BFD5F09A7A1FQ28238393-246F231F-ED91-48FF-82F4-9FD9F9EF7810Q33762715-FB4B3AA6-5986-4C94-93CE-08B50B81938DQ33940775-46C44BB7-4124-441D-A61A-971CE17AC468Q34147668-79B0EA19-6D19-4A76-A5F1-C672526E0825Q34633885-5B3E3CF4-9FF8-4A74-90F4-BFA018BB9C48Q34761998-5A9973D1-91DB-4AB0-8BF1-8514C4B4C4D9Q35071486-C99595B1-A3D5-4BD4-B105-A2EAF9F80C0AQ35091482-CE88F565-67DE-4DF4-BE7E-BC6436963AFEQ35143744-285C09DD-4541-470D-B14C-73592C35D891Q36257430-E2A95CC9-5E86-4197-A2ED-CECC6028558EQ36694173-63FC2FD6-F90C-4FF3-B1F9-CA3398FAF768Q36752192-C4EB4EEC-1173-47B4-BDB3-D838618D7B7AQ36773305-C1F2C7AC-5EB8-4C56-8C74-A590965BFA35Q36828567-9A0E07E4-3FBE-4811-9BF9-BE911EAF1063Q37510470-D1877B02-3328-48C3-944A-D3495FCBBDBBQ37921096-DA47B434-C6BD-49E6-87EC-7678B77BBD85Q41557948-FBB7E331-9893-4588-BA04-9C0D9CBFD467Q41862341-EC3BFD1C-2B62-4D92-A48D-C06C31289983Q42392815-EE5BB2FF-8EF8-4E92-A097-72216B7BC6D5Q47105077-F6893671-FBFC-4DC4-9A9D-FC37B065983FQ50014278-84450347-E301-4D66-8375-EB166268489A
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Altered molecular pathways in melanocytic lesions.
@en
type
label
Altered molecular pathways in melanocytic lesions.
@en
prefLabel
Altered molecular pathways in melanocytic lesions.
@en
P2093
P50
P356
P1476
Altered molecular pathways in melanocytic lesions
@en
P2093
Alberto Pisacane
Enrico Grosso
Maria Scatolini
Maurizia Mello Grand
Mauro Risio
Roberta Sirovich
P304
P356
10.1002/IJC.24899
P577
2010-04-01T00:00:00Z